Clinical outcomes of pyrazinamide-monoresistant Mycobacterium tuberculosis in Quebec

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 5, 2012, Pages 604-609

  Yee, D P ^a   Menzies, D ^a   Brassard, Paul ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Clinical outcome; Cure rates; Drug resistance; Mortality rates; Pyrazinamide; Tuberculosis

Indexed keywords

PYRAZINAMIDE; RIFAMPICIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANADA; CANADIAN; CONTROLLED STUDY; DEATH; DRUG TREATMENT FAILURE; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; TREATMENT DURATION; TUBERCULOSIS;

AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; QUEBEC; RECURRENCE; RETROSPECTIVE STUDIES; RIFAMPIN; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84859724698     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0376     Document Type: Article

References (35)

1. Nettleman M D. Multidrug-resistant tuberculosis: news from the front. JAMA 2005; 293: 2788-2790. (Pubitemid 40965091)
2. Health Canada. Tuberculosis. Drug resistance in Canada: reported susceptibility results of the Canadian tuberculosis laboratory surveillance system. Ottawa, ON, Canada: Health Canada, 2000.
3. Bloch A B, Cauthen G M, Onorato I M, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665-671. (Pubitemid 24061700)
4. Nguyen D, Brassard P, Westley J, et al. Widespread pyrazinamide-resistant mycobacterium tuberculosis family in a low-incidence setting. J Clin Microbiol 2003; 41: 2878-2883. (Pubitemid 36842274)
5. Sreevatsan S, Pan X, Zhang Y, Kreiswirth B N, Musser J M. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother 1997; 41: 636-640. (Pubitemid 27098417)
6. Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle Lung Dis 1997; 78: 117-122. (Pubitemid 28080549)
7. Scorpio A, Lindholm-Levy P, Heifets L, et al. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997; 41: 540-543. (Pubitemid 27098400)
8. Mestdagh M, Fonteyne P A, Realini L, et al. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999; 43: 2317-2319. (Pubitemid 29421225)
9. Marttila H J, Marjamaki M, Vyshnevskaya E, et al. pncA m utations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia. Antimicrob Agents Chemother 1999; 43: 1764-1766. (Pubitemid 29331264)
10. Lemaitre N, Sougakoff W, Truffot-Pernot C, Jarlier V. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase pncA. Antimicrob Agents Chemother 1999; 43: 1761-1763. (Pubitemid 29331263)
11. Cheng S J, Thibert L, Sanchez T, Heifets L, Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Myco bacterium tuberculosis: spread of a monoresistant strain in Que bec, Canada. Antimicrob Agents Chemother 2000; 44: 528-532. (Pubitemid 30117936)
12. Hewlett D Jr, Horn D L, Alfalla C. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA 1995; 273: 916-917.
13. Edlin B R, Tokars J L, Grieco M H, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514.
14. Webster P. World Bank approves loan to help Russia tackle HIV/AIDS and tuberculosis. Lancet 2003; 361: 1355.
15. Heifets L. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J Med Microbiol 2002; 51: 11-12. (Pubitemid 34060127)
16. Wayne L G. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis 1974; 109: 147-151.
17. Van Embden J D, Cave M D, Crawford J T, et al. Strain identification of mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409. (Pubitemid 23028649)
18. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914. (Pubitemid 27146535)
19. Mazars E, Lesjean S, Banuls A L, et al. High-resolution mini-satellite- based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci USA 2001; 98: 1901-1906. (Pubitemid 32165595)
20. Gross W M, Hawkins J E. Radiometric selective inhibition tests for differentiation of Mycobacterium tuberculosis, Mycobacterium bovis, and other mycobacteria. J Clin Microbiol 1985; 21: 565-568. (Pubitemid 15106511)
21. Menzies R, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis 1992; 146: 752-756.
22. Djuretic T, Herbert J, Drobniewski F, et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax 2002; 57: 477-482. (Pubitemid 34627978)
23. Farzad E, Holton D, Long R, et al. Drug resistance study of Mycobacterium tuberculosis in Canada, February 1, 1993 to January 31, 1994. Can J Public Health 2000; 91: 366-370.
24. Alland D, Kalkut G E, Moss A R, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-1716.
25. Small P M, Hopewell P C, Singh S P, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
26. Van Deutekom H, Hoijng S P, de Haas P E, et al. Clustered tuberculosis cases: do they represent recent transmission and can they be detected earlier? Am J Respir Crit Care Med 2004; 169: 806-810. (Pubitemid 38402455)
27. Brassard P, Henry K A, Schwartzman K, Jomphe M, Olsen S H. Geography and genealogy of the human host harbouring a distinctive drug-resistant strain of tuberculosis. Infect Genet Evol 2008; 8: 247-257.
28. Nguyen L N, Gilbert G L, Marks G B. Molecular epidemiology of tuberculosis and recent developments in understanding the epidemiology of tuberculosis. Respirology 2004; 9: 313-319. (Pubitemid 39382112)
29. Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull World Health Organ 2002; 80: 477-482. (Pubitemid 34632826)
30. Kulaga S, Behr M A, Schwartzman K. Genetic fingerprinting in the study of tuberculosis transmission. CMAJ 1999; 161: 1165-1169. (Pubitemid 29515779)
31. Braden C R, Templeton G L, Cave M D, et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997; 175: 1446-1452. (Pubitemid 27225049)
32. East African/British Medical Research Councils. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report. Lancet 1973; 1: 1331-1338.
33. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: the results up to 24 months. Tubercle 1979; 60: 201-210.
34. Santha T, Nazareth O, Krishnamurthy M S, et al. Treatment of pulmonary tuberculosis with short course chemotherapy in South India - 5-year follow-up. Tubercle 1989; 70: 229-234. (Pubitemid 20001742)
35. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-2545. (Pubitemid 30324196)